JP2024528731A5 - - Google Patents
Info
- Publication number
- JP2024528731A5 JP2024528731A5 JP2024505211A JP2024505211A JP2024528731A5 JP 2024528731 A5 JP2024528731 A5 JP 2024528731A5 JP 2024505211 A JP2024505211 A JP 2024505211A JP 2024505211 A JP2024505211 A JP 2024505211A JP 2024528731 A5 JP2024528731 A5 JP 2024528731A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- ibudilast
- composition according
- administered
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225820P | 2021-07-26 | 2021-07-26 | |
| US63/225,820 | 2021-07-26 | ||
| PCT/US2022/038157 WO2023009425A1 (en) | 2021-07-26 | 2022-07-25 | Ibudilast for preventing eye cancer metastasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528731A JP2024528731A (ja) | 2024-07-30 |
| JP2024528731A5 true JP2024528731A5 (https=) | 2025-07-31 |
Family
ID=82851760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505211A Pending JP2024528731A (ja) | 2021-07-26 | 2022-07-25 | 眼癌転移を予防するためのイブジラスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12005049B2 (https=) |
| EP (1) | EP4376838A1 (https=) |
| JP (1) | JP2024528731A (https=) |
| CN (1) | CN117940128A (https=) |
| CA (1) | CA3226898A1 (https=) |
| WO (1) | WO2023009425A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12005049B2 (en) | 2021-07-26 | 2024-06-11 | Medicinova, Inc. | Methods of preventing cancer metastasis |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395747B1 (en) | 1998-08-10 | 2002-05-28 | Sauro Sakoda | Remedies for multiple sclerosis |
| JP4954085B2 (ja) | 2004-12-06 | 2012-06-13 | メディシノバ， インコーポレイテッド | 神経障害性疼痛及びその関連する症状を治療するためのイブジラスト |
| US8138201B2 (en) | 2007-07-11 | 2012-03-20 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| EP2858635A1 (en) * | 2012-06-11 | 2015-04-15 | The Regents of The University of California | Inhibitors of hippo-yap signaling pathway |
| KR102462638B1 (ko) | 2014-11-26 | 2022-11-03 | 메디시노바, 인크. | 이부딜라스트와 릴루졸의 배합물 및 이의 사용방법 |
| WO2018119262A1 (en) | 2016-12-22 | 2018-06-28 | Medicinova, Inc. | Methods of treating glioblastoma multiforme using ibudilast |
| ES2959799T3 (es) | 2018-02-12 | 2024-02-28 | Medicinova Inc | Métodos para suprimir células supresoras de origen mieloide en pacientes |
| JP2021512921A (ja) | 2018-02-12 | 2021-05-20 | メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
| WO2020076809A1 (en) | 2018-10-09 | 2020-04-16 | Medicinova, Inc. | Combination of ibudilast and interferon-beta and methods of using same |
| CN112804999B (zh) | 2018-10-19 | 2024-03-15 | 美迪诺亚公司 | 通过异丁司特治疗眼科疾病/病症或损伤的方法 |
| EP4034090A1 (en) | 2019-09-23 | 2022-08-03 | MediciNova, Inc. | Ibudilast oral formulations and methods of using same |
| CA3174413A1 (en) | 2020-04-06 | 2021-10-14 | Yuichi Iwaki | Methods of reducing plasma level of macrophage migratory inhibitory factor in patients with ibudilast |
| WO2022164948A1 (en) | 2021-01-29 | 2022-08-04 | Medicinova, Inc. | Methods of treating chemical gas exposure |
| US12005049B2 (en) | 2021-07-26 | 2024-06-11 | Medicinova, Inc. | Methods of preventing cancer metastasis |
| CA3231869A1 (en) | 2021-09-21 | 2023-03-30 | Medicinova, Inc. | Ibudilast in combination therapy for use in the treatment of glioblastoma |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
| CN118973574A (zh) | 2022-02-01 | 2024-11-15 | 美迪诺亚公司 | 异丁司特治疗新冠肺炎后遗症的用途 |
-
2022
- 2022-07-25 US US17/872,855 patent/US12005049B2/en active Active
- 2022-07-25 JP JP2024505211A patent/JP2024528731A/ja active Pending
- 2022-07-25 WO PCT/US2022/038157 patent/WO2023009425A1/en not_active Ceased
- 2022-07-25 CA CA3226898A patent/CA3226898A1/en active Pending
- 2022-07-25 EP EP22754252.9A patent/EP4376838A1/en active Pending
- 2022-07-25 CN CN202280059689.8A patent/CN117940128A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| JP2023503068A5 (https=) | ||
| JP2023503071A5 (https=) | ||
| JP2022514269A5 (https=) | ||
| JP2021527092A5 (https=) | ||
| JP2024528731A5 (https=) | ||
| JP2021512149A5 (https=) | ||
| JP2024507810A5 (https=) | ||
| JP2022521233A5 (https=) | ||
| JP2023523706A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| KR20240032789A (ko) | 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물 | |
| JP2020522560A5 (https=) | ||
| FI3713576T3 (fi) | Yhdiste kaavan (i) mukaan ja ponatinibi käytettäväksi bcr-abl-mutaatioiden kanssa esiintyvän kroonisen myelooisen leukemian hoidossa | |
| WO2007000764A2 (en) | Compositions and methods for enhancement of sexual function | |
| JP2016505050A5 (https=) | ||
| JP2022553888A5 (https=) | ||
| JP2021517128A5 (https=) | ||
| JP2024540439A5 (https=) | ||
| JP2024520690A5 (https=) | ||
| IE851848L (en) | Propiophenone compound against sexual dysfunction | |
| WO2004006908A1 (ja) | 色素沈着改善治療薬 | |
| JP2022505184A5 (https=) | ||
| EP2830605B1 (en) | A combination medicament comprising phenylephrine and paracetamol | |
| JP2024531799A5 (https=) |